The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Eclampsia in the 21st century
Open accessAbstract
The reported incidence of eclampsia is 1.6-10 per 10,000 deliveries in developed countries, where as it is 50-151 per 10,000 deliveries in developing countries. In addition, low resource countries have substantially higher rates of maternal and perinatal mortalities and morbidities. This disparity in incidence and pregnancy outcomes maybe related to universal access to prenatal care, early detection of preeclampsia, timely delivery, and availability of health care resources in developed as compared to developing countries. Because of its infrequency in developed countries, many obstetric providers and maternity units have minimal to no experience in acute management of eclampsia and its complications. Therefore, clear protocols for prevention of eclampsia in those with severe preeclampsia and acute treatment of eclamptic seizures at all levels of health care are required for better maternal and neonatal outcomes. Eclamptic seizure will occur in 2% of women with preeclampsia with severe features who are not receiving magnesium sulfate, and in less than 0.6% in those receiving magnesium. The pathogenesis of an eclamptic seizure is not well understood, however blood brain barrier (BBB) disruption with passage of fluid, ions and plasma protein into the brain parenchyma remains the leading theory. New data suggest that BBB permeability may increase by circulating factors found in preeclamptic women plasma such as vascular endothelial growth factor and placental growth factor. The management of an eclamptic seizure will include supportive care to prevent serious maternal injury, magnesium sulfate for prevention of recurrent seizures and promoting delivery. While routine imagining following eclamptic seizure is not recommended, the classic finding is referred to as posterior reversible encephalopathy syndrome (PRES). The majority of patients with PRES will show complete resolution of the imaging finding within 1-2 weeks, but routine imaging follow up is unnecessary unless there are findings of intracranial hemorrhage, infraction or ongoing neurologic deficit. Eclampsia is associated with increased risk for maternal mortality and morbidity such as placental abruption, disseminated intravascular coagulation, pulmonary edema, aspiration pneumonia, cardiopulmonary arrest and acute renal failure. Furthermore, a history of eclamptic seizure is may be related to long-term cardiovascular risk and cognitive difficulties related to memory and concentration years after the index pregnancy. Finally, limited data suggest that placental growth factor levels in preeclamptic women are superior to clinical markers in prediction of adverse pregnancy outcomes. This data may be extrapolated to prediction of eclampsia in future studies. This summary of available evidence provides data and expert opinion on possible pathogenesis of eclampsia, imagining findings, differential diagnosis, and stepwise approach regarding management of eclampsia prior to delivery and during the postpartum, as well as current recommendations for prevention of eclamptic seizure in women with preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global causes of maternal death: a WHO systematic analysis
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70227-x · Cited by 6,582
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationGestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
Tranquilli, A. L., Dekker, G., Magee, L., Roberts, J., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,417
Self-citation
Cited by
The role of immune cells and mediators in preeclampsia
Deer, E., Herrock, O., Campbell, N., Cornelius, D., Fitzgerald, S., Amaral, L. M., & LaMarca, B. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00670-0 · Cited by 290
Metadata
- Authors
- Fishel Bartal, M., & Sibai, B. M.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 226
- Issue
- 2
- Pages
- S1237-S1253
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3088249090
- Cited by
- 255
- References
- 118
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eclampsia in the 21st century. https://app.cochat.ai/papers/10.1016/j.ajog.2020.09.037
- The paper
- Fishel Bartal, M., & Sibai, B. M. (2022). Eclampsia in the 21st century. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2020.09.037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.